ADAM10 and colorectal carcinoma: Even though many of the selected candidates had been reported as potential markers for CRC, only three targets (ADAM10, CD59 and TSPAN9) showed good power (AUC > 0.8) to discriminate CRC patients from HCs in the current study (Table 2 and Figure S4).